Dolutegravir – a review of the pharmacology, efficacy, and safety in the treatment of HIV

Dolutegravir is the newest integrase strand transfer inhibitor to be approved for the treatment of human immunodeficiency virus (HIV) infection. Dolutegravir is equivalent or superior to existing treatment regimens in both treatment-naïve and treatment-experienced patients including those with previ...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandel, Christopher E, Walmsley, Sharon L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500604/
https://www.ncbi.nlm.nih.gov/pubmed/26185421
http://dx.doi.org/10.2147/DDDT.S84850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500604/
https://www.ncbi.nlm.nih.gov/pubmed/26185421
http://dx.doi.org/10.2147/DDDT.S84850

Ejemplares similares